Global Colorectal Cancer Molecular Diagnostics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01240159

Publication Date:

January 11, 2024

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Colorectal Cancer Molecular Diagnostics market size was valued at US$ 587.5 million in 2023. With growing demand in downstream market, the Colorectal Cancer Molecular Diagnostics is forecast to a readjusted size of US$ 1533.3 million by 2030 with a CAGR of 14.7% during review period.
The research report highlights the growth potential of the global Colorectal Cancer Molecular Diagnostics market. Colorectal Cancer Molecular Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Colorectal Cancer Molecular Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Colorectal Cancer Molecular Diagnostics market.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
Key Features:
The report on Colorectal Cancer Molecular Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Colorectal Cancer Molecular Diagnostics market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction PCR, Molecular Hybridization), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Colorectal Cancer Molecular Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Colorectal Cancer Molecular Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Colorectal Cancer Molecular Diagnostics industry. This include advancements in Colorectal Cancer Molecular Diagnostics technology, Colorectal Cancer Molecular Diagnostics new entrants, Colorectal Cancer Molecular Diagnostics new investment, and other innovations that are shaping the future of Colorectal Cancer Molecular Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Colorectal Cancer Molecular Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Colorectal Cancer Molecular Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Colorectal Cancer Molecular Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Colorectal Cancer Molecular Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Colorectal Cancer Molecular Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Colorectal Cancer Molecular Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Colorectal Cancer Molecular Diagnostics market.
Market Segmentation:
Colorectal Cancer Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Segmentation by application
Hospital
Third-Party Testing Agency
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Colorectal Cancer Molecular Diagnostics Market Size 2019-2030
2.1.2 Colorectal Cancer Molecular Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Colorectal Cancer Molecular Diagnostics Segment by Type
2.2.1 Polymerase Chain Reaction PCR
2.2.2 Molecular Hybridization
2.2.3 Biochip
2.2.4 Others
2.3 Colorectal Cancer Molecular Diagnostics Market Size by Type
2.3.1 Colorectal Cancer Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Colorectal Cancer Molecular Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Colorectal Cancer Molecular Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Third-Party Testing Agency
2.4.3 Others
2.5 Colorectal Cancer Molecular Diagnostics Market Size by Application
2.5.1 Colorectal Cancer Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Colorectal Cancer Molecular Diagnostics Market Size Market Share by Application (2019-2024)
3 Colorectal Cancer Molecular Diagnostics Market Size by Player
3.1 Colorectal Cancer Molecular Diagnostics Market Size Market Share by Players
3.1.1 Global Colorectal Cancer Molecular Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Colorectal Cancer Molecular Diagnostics by Regions
4.1 Colorectal Cancer Molecular Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Colorectal Cancer Molecular Diagnostics Market Size Growth (2019-2024)
4.3 APAC Colorectal Cancer Molecular Diagnostics Market Size Growth (2019-2024)
4.4 Europe Colorectal Cancer Molecular Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Colorectal Cancer Molecular Diagnostics Market Size by Country (2019-2024)
5.2 Americas Colorectal Cancer Molecular Diagnostics Market Size by Type (2019-2024)
5.3 Americas Colorectal Cancer Molecular Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Colorectal Cancer Molecular Diagnostics Market Size by Region (2019-2024)
6.2 APAC Colorectal Cancer Molecular Diagnostics Market Size by Type (2019-2024)
6.3 APAC Colorectal Cancer Molecular Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics by Country (2019-2024)
7.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2019-2024)
7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Colorectal Cancer Molecular Diagnostics Market Forecast
10.1 Global Colorectal Cancer Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Colorectal Cancer Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Colorectal Cancer Molecular Diagnostics Forecast
10.1.3 APAC Colorectal Cancer Molecular Diagnostics Forecast
10.1.4 Europe Colorectal Cancer Molecular Diagnostics Forecast
10.1.5 Middle East & Africa Colorectal Cancer Molecular Diagnostics Forecast
10.2 Americas Colorectal Cancer Molecular Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Colorectal Cancer Molecular Diagnostics Market Forecast
10.2.2 Canada Colorectal Cancer Molecular Diagnostics Market Forecast
10.2.3 Mexico Colorectal Cancer Molecular Diagnostics Market Forecast
10.2.4 Brazil Colorectal Cancer Molecular Diagnostics Market Forecast
10.3 APAC Colorectal Cancer Molecular Diagnostics Forecast by Region (2025-2030)
10.3.1 China Colorectal Cancer Molecular Diagnostics Market Forecast
10.3.2 Japan Colorectal Cancer Molecular Diagnostics Market Forecast
10.3.3 Korea Colorectal Cancer Molecular Diagnostics Market Forecast
10.3.4 Southeast Asia Colorectal Cancer Molecular Diagnostics Market Forecast
10.3.5 India Colorectal Cancer Molecular Diagnostics Market Forecast
10.3.6 Australia Colorectal Cancer Molecular Diagnostics Market Forecast
10.4 Europe Colorectal Cancer Molecular Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Colorectal Cancer Molecular Diagnostics Market Forecast
10.4.2 France Colorectal Cancer Molecular Diagnostics Market Forecast
10.4.3 UK Colorectal Cancer Molecular Diagnostics Market Forecast
10.4.4 Italy Colorectal Cancer Molecular Diagnostics Market Forecast
10.4.5 Russia Colorectal Cancer Molecular Diagnostics Market Forecast
10.5 Middle East & Africa Colorectal Cancer Molecular Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Colorectal Cancer Molecular Diagnostics Market Forecast
10.5.2 South Africa Colorectal Cancer Molecular Diagnostics Market Forecast
10.5.3 Israel Colorectal Cancer Molecular Diagnostics Market Forecast
10.5.4 Turkey Colorectal Cancer Molecular Diagnostics Market Forecast
10.5.5 GCC Countries Colorectal Cancer Molecular Diagnostics Market Forecast
10.6 Global Colorectal Cancer Molecular Diagnostics Forecast by Type (2025-2030)
10.7 Global Colorectal Cancer Molecular Diagnostics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Information
11.1.2 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product Offered
11.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Diagnostics Main Business Overview
11.1.5 Roche Diagnostics Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Colorectal Cancer Molecular Diagnostics Product Offered
11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Information
11.3.2 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product Offered
11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Main Business Overview
11.3.5 Thermo Fisher Latest Developments
11.4 Qiagen
11.4.1 Qiagen Company Information
11.4.2 Qiagen Colorectal Cancer Molecular Diagnostics Product Offered
11.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Qiagen Main Business Overview
11.4.5 Qiagen Latest Developments
11.5 Illumina
11.5.1 Illumina Company Information
11.5.2 Illumina Colorectal Cancer Molecular Diagnostics Product Offered
11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Illumina Main Business Overview
11.5.5 Illumina Latest Developments
11.6 Biomerieux
11.6.1 Biomerieux Company Information
11.6.2 Biomerieux Colorectal Cancer Molecular Diagnostics Product Offered
11.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Biomerieux Main Business Overview
11.6.5 Biomerieux Latest Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Information
11.7.2 Bio-Rad Colorectal Cancer Molecular Diagnostics Product Offered
11.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio-Rad Main Business Overview
11.7.5 Bio-Rad Latest Developments
11.8 Agilent
11.8.1 Agilent Company Information
11.8.2 Agilent Colorectal Cancer Molecular Diagnostics Product Offered
11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Agilent Main Business Overview
11.8.5 Agilent Latest Developments
11.9 Daangene
11.9.1 Daangene Company Information
11.9.2 Daangene Colorectal Cancer Molecular Diagnostics Product Offered
11.9.3 Daangene Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Daangene Main Business Overview
11.9.5 Daangene Latest Developments
11.10 Amoydx
11.10.1 Amoydx Company Information
11.10.2 Amoydx Colorectal Cancer Molecular Diagnostics Product Offered
11.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Amoydx Main Business Overview
11.10.5 Amoydx Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂